Cardiac risk factors and events in patients with prostate cancer commencing androgen deprivation therapy: analysis from a tertiary care centre in the Middle East

BACKGROUND: Androgen deprivation therapy (ADT) is the mainstay of treatment for advanced prostate cancer, improving symptoms and prolonging survival. There is an association between ADT use and cardiovascular (CV) events, particularly in patients with preexisting risk factors. In men diagnosed with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hassan, Mona Ali, Telvizian, Talar, Abohelwa, Mostafa, Mukherji, Deborah, Skouri, Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666276/
https://www.ncbi.nlm.nih.gov/pubmed/36405935
http://dx.doi.org/10.3332/ecancer.2022.1445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666276/
https://www.ncbi.nlm.nih.gov/pubmed/36405935
http://dx.doi.org/10.3332/ecancer.2022.1445

Ejemplares similares